Company Revenue

The company grew more than 20% in 2023 as it consistently wins share in its Trauma and Deformity business....

The company grew nearly 80% in 2023, with 104% growth in North America on the strength of CERAMENT G sales...

The company grew in the mid-single-digits on a pro forma basis in 2023 and is focused on leveraging its...

The company grew 19% in 2023 despite contending with supply chain constraints and could growth another 20% in 2024....

The company's MACI revenues grew nearly 25% in 2023 and Vericel expects the launch of MACI Arthro in the third...

The company grew more than 37% in 2023 as its procedural solutions win over surgeons in a disrupted spine market....

The company grew more than 30% in 2023 and added another $750 million to its already massive $5 billion total...

The company's orthopedic sales grew in the mid-single-digits for 2023 but were hamstrung by supply constraints and headwinds in China....

The company's orthopedic sales grew in the mid-teens for 2023 and is likely to be a $1 billion recon player...

The company finished 2023 with reported sales growth over 50% as it works to integrate NuVasive and reach a steady...